CBLN1 and heart failure: The current study showed that higher plasma levels of Cer-16 and SM-16 were associated with increased risk of heart failure, and higher levels of Cer-22, SM-20, SM-22, and SM-24 with decreased risk of heart failure (Lemaitre et al., 2019; Fretts et al., 2021).